Mangalam Drugs and Organics Ltd — Quarterly Results & Earnings

₹27.15

-4.91%

Profit Growth YoY-369.52%Latest quarter

Sales Growth YoY-38.03%Latest quarter

Sales CAGR 5Y2.42%5 year compound

Profit CAGR 5Y-3.72%5 year compound

📋

Quarterly Performance

YoY Profit Growth-369.52%

🔴 Significant decline

YoY Sales Growth-38.03%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

9.61%

EPS Growth 5Y

-3.72%

Interest Coverage

Higher = safer debt servicing

-0.33

ROE

4.71%

ROCE

8.03%

💡

Growth Analysis

Mangalam Drugs and Organics Ltd reported YoY profit growth of -369.52% and revenue growth of -38.03% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 2.42% and profits at -3.72% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Mangalam Drugs and Organics Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.